Provided by Tiger Trade Technology Pte. Ltd.

Evolent Health

2.85
-0.0400-1.38%
Post-market: 2.860.0100+0.35%19:31 EST
Volume:2.87M
Turnover:8.22M
Market Cap:318.06M
PE:-1.81
High:2.94
Open:2.88
Low:2.82
Close:2.89
52wk High:12.07
52wk Low:2.82
Shares:111.60M
Float Shares:86.94M
Volume Ratio:0.87
T/O Rate:3.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5719
EPS(LYR):-0.8149
ROE:-12.40%
ROA:0.12%
PB:0.38
PE(LYR):-3.50

Loading ...

Evolent Health Inc. kündigt Veröffentlichung von Finanzzahlen an

Reuters
·
Feb 05

Evolent Health Is Maintained at Buy by BTIG

Dow Jones
·
Feb 02

Evolent Health Inc : Btig Cuts Target Price to $10 From $16

THOMSON REUTERS
·
Feb 02

Evolent Health Is Maintained at Buy by Citigroup

Dow Jones
·
Jan 10

Evolent Health price target lowered to $6 from $9.50 at Citi

TIPRANKS
·
Jan 09

Evolent Health Inc : RBC Resumes Coverage With Sector Perform Rating; Target Price $5

THOMSON REUTERS
·
Jan 09

Evolent Health Is Maintained at Market Outperform by Citizens

Dow Jones
·
Jan 06

Evolent Health Inc. Files Initial Statement of Beneficial Ownership for Chief Financial Officer Mario Ramos

Reuters
·
Jan 06

BRIEF-Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08

Reuters
·
Jan 03

Evolent Reports Inducement Award Under Nyse Listing Rule 303a.08

THOMSON REUTERS
·
Jan 03

Syra Health Names Gregory R. Alexander as CEO

Reuters
·
Dec 18, 2025

Evolent Health Inc. Files Initial Beneficial Ownership Statement for Director Jill D. Smith

Reuters
·
Dec 13, 2025

Evolent Health Closes Privia Management Company Acquisition

Reuters
·
Dec 08, 2025

Evolent Health Inc : Piper Sandler Cuts Target Price to $6 From $18

THOMSON REUTERS
·
Dec 02, 2025

Evolent Health Inc - Reaffirms Q4 2025 Revenue Guidance - SEC Filing

THOMSON REUTERS
·
Dec 02, 2025

Evolent Health Inc - Reaffirms Q4 2025 Adj Ebitda Guidance - SEC Filing

THOMSON REUTERS
·
Dec 02, 2025

Evolent Health Announces Retirement of Director Cheryl Scott and Appointment of Independent Director Smith

Reuters
·
Dec 02, 2025

Canaccord Genuity Keeps Their Buy Rating on Evolent Health (EVH)

TIPRANKS
·
Nov 25, 2025

Evolent Health Is Maintained at Buy by Citigroup

Dow Jones
·
Nov 22, 2025

Director’s Bold Move: Major Stock Purchase Signals Confidence in Evolent Health

TIPRANKS
·
Nov 20, 2025